Proteome Sciences (LON:PRM) Trading Up 34.6% – Here’s Why

Proteome Sciences plc (LON:PRM) shot up 34.6% on Wednesday . The stock traded as high as GBX 2 and last traded at GBX 1.89. Approximately 782,692 shares traded hands during trading, an increase of 87% from the average session volume of 417,714 shares. The stock had previously closed at GBX 1.40.

Proteome Sciences Stock Performance

The business has a 50-day simple moving average of GBX 1.59 and a 200 day simple moving average of GBX 1.87. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The firm has a market cap of £6.61 million, a PE ratio of -1.81 and a beta of 0.15.

Proteome Sciences (LON:PRM) last released its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%. The firm had revenue of GBX 376 million for the quarter.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.